Martingale Asset Management »

Neurocrine Biosciences shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2012-12-31 $92k 12k 7.54

More positions owned by Martingale Asset Management

Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Apple (AAPL)
Microsoft Corporation (MSFT)
Berkshire Hathaway (BRK.B)
JPMorgan Chase & Co. (JPM)
Wal-Mart Stores (WMT)
Facebook Inc cl a (META)
Visa (V)
At&t (T)
Cisco Systems (CSCO)
UnitedHealth (UNH)
Costco Wholesale Corporation (COST)
MasterCard Incorporated (MA)
Exxon Mobil Corporation (XOM)

View all positions for Martingale Asset Management

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
State Street Corporation
Dodge & Cox
Citadel Advisors
Renaissance Technologies
AQR Capital Management
Geode Capital Management
Bellevue Group
Morgan Stanley
T. Rowe Price Associates
Wellington Management Company
Jpmorgan Chase & Co
Ubs Global Asset Management Americas
Goldman Sachs Group

View all funds holding Neurocrine Biosciences